Keywords
chronic gastritis
peptic ulcer disease
hemodialysis
How to Cite
Abstract
Background: Gastrointestinal complications are frequent in patients with renal disease and are responsible for substantial morbidity and mortality among these patients in developing countries. Many times, these patients are subjected to endoscopic evaluation and mucosal biopsies are taken for definitive diagnosis. Long before the routine uses of dialysis, patients dying of uremia were found to have a high incidence of gastrointestinal abnormalities (1).
Matherials and methods: The survey included 240 persons; 120 of them were dialysis patients, while the remaining 120 were healthy individuals who served as a control group. 54 (45%) of the patients with hemodialysis were females while 66 (55%) of them were males with mean age: 58.20 ± 18.00 years. These patients had been in dialysis for more than 12 years at the Clinic for Nephrology in Skopje and the Clinical Hospital in Tetovo.
Results: Gastrointestinal complications were present in 20 (37.0%) out of 54 females while 26 (39.4%) out of 66 males presented with duodenal bulbar ulcers. 84 patients [(females-38/54 (70.4%) and males-46/66 (85.2%)] of the total number of 120 examined patients were found to have chronic gastritis.
In conclusion, we found that the incidence of PUD was more than 10 times higher in CKD patients than in those without CKD over a 3-year period between 2008-2010. CKD patients receiving HD, NSAID, or clopidogrel had an increased risk of PUD, compared to CKD patients not receiving these treatments.
References
Zuckerman GR, Cornette GL, et al. Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med 102: 588, 1985.
Margolis DM, Saylor JL, et al. Upper gastrointestinal disease in chronic renal failure: a prospective evaluation. Arch Intern Med 138: 1214, 1978.
McNamee PT, Moore GW, McGeown M, Doherty CC, Collins BJ: Gastric emptying in chronic renal failure. Br Med J 291:310, 1985.
Gold CH, Morley JE, Viljoen M, et al. Gastric acid secretion and serum gastrin levels in patients with chronic renal failure on regular hemodialysis. Nephron. 1980;25:92.
Muto S, Murayama N, Asano Y, et al. Hypergastrinemia and achlorhydria in chronic renal failure. Nephron. 1985;40:143.
Ghonaimy E, Barsoum R, Soliman M, et al. Serum gastrin in chronic renal failure: morphological and physiological correlation. Nephron. 1985;39:86.
Paronen I, Ala-Kaila K, Rantala I, et al. Gastric parietal, chief, and G-cell densities in chronic renal failure. Scand J Gastroenterol. 1991;26:696–700.
Fisher RS, Lipshutz W, Cohen S. The hormonal regulation of pyloric sphincter function. J Clin Invest. 1973;52:1289.
McNamee PT, Moore GW, et al. Gastric emptying in chronic renal failure. Br Med J 291:310, 1985
Wright RA, Clemente R, Wathen R: Gastric emptying in patients with chronic renal failure receiving hemodialysis. Arch Intern Med 144: 495, 1984
Soffer EE, Geva B, et al. Gastric emptying in chronic renal failure patients on hemodialysis. J Clin Gastroenterol 9: 651, 1987
Brown-Cartwright D, Smith HJ, Feldman M: Gastric emptying of an indigestible solid in patients with endstage renal disease on continuous ambulatory peritoneal dialysis. Gastroenterology 95: 49, 1988
Feldman M, Schiller LR: Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98: 378, 1983.
Franzin G, Musola R, Mencarelli R: Morphological changes of the gastroduodenal mucosa in regular dialysis uraemic patients. Histopathology 6: 492, 1982.
Zuckerman GR, et al. Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med 102: 588, 1985
Malfertheiner P, Chan FK, et al. Peptic ulcer disease. Lancet,2009; 374: 1449–14526.
Luo JC, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis.2012; CMAJ 183: E1345–1352.
Tseng GY, Lin HJ, Fang CT, et al. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.2007; Aliment Pharmacol Ther 26: 925–933.
Tseng GY, Lin HJ, Fang CT, et al. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study.2007; Aliment Pharmacol Ther 26: 925–933.
Sugimoto M, Sakai K, et al. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. (2009) Kidney Int 75: 96– 104.
Wen CP, Cheng TY, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.2008; Lancet 371: 2173–2182.
Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. (2010) Am J Med 123: : 358–366
Chen YT, Yang WC, et al. Comparison of peptic ulcer disease risk between peritoneal and hemodialysis patients. 2010. Am J Nephrol 32: 212– 218
Wasse H, Gillen DL, Ball AM, et a. Risk factors for upper gastrointestinal bleeding among end- stage renal disease patients. (2003) Kidney Int 64: 1455–1461
Hsu PI, Lai KH, Liu CP Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis. (2011) Gastro-enterology 140: 791–798]
Hsu PI New look at antiplatelet agent-related peptic ulcer: An update of prevention and treatment. (2012) Journal of Gastroenterology and Hepatology 27: 654–661
Peng YL, Leu HB, Luo JC, et al.Diabetes is an independent risk factor for peptic ulcer bleeding: a nationwide population-based cohort study. (2013) Journal of Gastroenterology and Hepatology,648- 730.
Ethier J, Bragg-Gresham JL, Piera L, Akizawa T, Asano Y, et al. Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2007), Am J Kidney Dis 50: 602–615
Laine L, Maller ES, Yu C, Quan H, Simon T. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double- blind trial. (2004) Gastroenterology 127: 395–406
Éthier J, Bragg-Gresham JL, Piera L, Akizawa T, Asano Y, et al. (2007) Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 50: 602–615.
Chong VH. Impact of duration of hemodialysis on gastrointestinal symptoms in patients with end stage renal failure. J Gastrointestin Liver Dis. 2010;19(4):462–463.
Flobert C, Cellier C, Berger A, et al. Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol. 2000;95(1): 195–198
Dalle IJ, Maes BD, Geboes KP, et al. Crohn’s-like changes in the colon due to mycophenolate? Colorectal Dis. 2005;7:27–34
Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13 (Suppl. l):S37–S40. [2] Khedmat H, Ahmadzad-Asl M,
Amini M, et al. Gastroduodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc. 2007;39(4):1003–1007. [3] Gold CH, Morley JE, Viljoen M, et al. Gastric acid secretion and serum gastrin levels in patients with chronic renal failure on regular hemodialysis. Nephron. 1980;25:92. [4] ]
Paronen I, Ala-Kaila K, Rantala I, et al. Gastric parietal, chief, and G-cell densities in chronic renal failure. Scand J Gastroenterol. 1991;26:696–700.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.